Cargando…
Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey
INTRODUCTION: Management of a clinical condition is patient centric. Interdisciplinary coordination plays an influential role in patient management. Pharmacology deals with the study of drugs. Clinical pharmacology deals with applied aspects of pharmacology in addition to clinical research. METHODOL...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615618/ https://www.ncbi.nlm.nih.gov/pubmed/36305906 http://dx.doi.org/10.1007/s00228-022-03409-9 |
_version_ | 1784820461277806592 |
---|---|
author | Krishnamurthy, Manjunath Nookala Pradosh, Anupama Varghese, Diana Halder, Soutik |
author_facet | Krishnamurthy, Manjunath Nookala Pradosh, Anupama Varghese, Diana Halder, Soutik |
author_sort | Krishnamurthy, Manjunath Nookala |
collection | PubMed |
description | INTRODUCTION: Management of a clinical condition is patient centric. Interdisciplinary coordination plays an influential role in patient management. Pharmacology deals with the study of drugs. Clinical pharmacology deals with applied aspects of pharmacology in addition to clinical research. METHODOLOGY: We set up a survey to assess the perceptions of clinical pharmacologists (CPs) regarding their roles and about clinical pharmacology courses in India. The survey was administered via a Google questionnaire sent via LinkedIn, Email, or WhatsApp to 100 CP’s working in India. RESULTS: Respondents to the questionnaire were working as CPs. They were either postgraduate in pharmacology (MD pharmacology (doctor of medicine in pharmacology) 60.2%) or had a super-specialization degree in clinical pharmacology (DM clinical pharmacology (doctorate in medicine in clinical pharmacology) (34.7%)) or other pharma postgraduates. They were working in pharmaceutical companies (41.8%), hospitals (26.5%), or academic institutions (30.6%). When the responses from the respondents were stratified by qualification or experience, they showed that most of the CPs felt that the CPs played a significant role in academia, pharmaceutical organizations, hospitals, and drug regulatory bodies. CONCLUSIONS: All the CPs opined that training during the postgraduation course was not sufficient to be qualified as CP. There was no consensus among the CPs on the benefit of existing certification courses in clinical research. However, they felt that the centres offering these courses should be accredited, and the curriculum should be uniform. Respondents opined that CPs’ patient management role could be improved by collaborating with clinicians and organizing workshops and conferences. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00228-022-03409-9. |
format | Online Article Text |
id | pubmed-9615618 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-96156182022-10-28 Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey Krishnamurthy, Manjunath Nookala Pradosh, Anupama Varghese, Diana Halder, Soutik Eur J Clin Pharmacol Research INTRODUCTION: Management of a clinical condition is patient centric. Interdisciplinary coordination plays an influential role in patient management. Pharmacology deals with the study of drugs. Clinical pharmacology deals with applied aspects of pharmacology in addition to clinical research. METHODOLOGY: We set up a survey to assess the perceptions of clinical pharmacologists (CPs) regarding their roles and about clinical pharmacology courses in India. The survey was administered via a Google questionnaire sent via LinkedIn, Email, or WhatsApp to 100 CP’s working in India. RESULTS: Respondents to the questionnaire were working as CPs. They were either postgraduate in pharmacology (MD pharmacology (doctor of medicine in pharmacology) 60.2%) or had a super-specialization degree in clinical pharmacology (DM clinical pharmacology (doctorate in medicine in clinical pharmacology) (34.7%)) or other pharma postgraduates. They were working in pharmaceutical companies (41.8%), hospitals (26.5%), or academic institutions (30.6%). When the responses from the respondents were stratified by qualification or experience, they showed that most of the CPs felt that the CPs played a significant role in academia, pharmaceutical organizations, hospitals, and drug regulatory bodies. CONCLUSIONS: All the CPs opined that training during the postgraduation course was not sufficient to be qualified as CP. There was no consensus among the CPs on the benefit of existing certification courses in clinical research. However, they felt that the centres offering these courses should be accredited, and the curriculum should be uniform. Respondents opined that CPs’ patient management role could be improved by collaborating with clinicians and organizing workshops and conferences. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00228-022-03409-9. Springer Berlin Heidelberg 2022-10-28 2022 /pmc/articles/PMC9615618/ /pubmed/36305906 http://dx.doi.org/10.1007/s00228-022-03409-9 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Research Krishnamurthy, Manjunath Nookala Pradosh, Anupama Varghese, Diana Halder, Soutik Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey |
title | Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey |
title_full | Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey |
title_fullStr | Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey |
title_full_unstemmed | Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey |
title_short | Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey |
title_sort | clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615618/ https://www.ncbi.nlm.nih.gov/pubmed/36305906 http://dx.doi.org/10.1007/s00228-022-03409-9 |
work_keys_str_mv | AT krishnamurthymanjunathnookala clinicalpharmacologistfromtheeyesofaclinicalpharmacologistaquestionnairebasedsurvey AT pradoshanupama clinicalpharmacologistfromtheeyesofaclinicalpharmacologistaquestionnairebasedsurvey AT varghesediana clinicalpharmacologistfromtheeyesofaclinicalpharmacologistaquestionnairebasedsurvey AT haldersoutik clinicalpharmacologistfromtheeyesofaclinicalpharmacologistaquestionnairebasedsurvey |